Clinical Research Directory
Browse clinical research sites, groups, and studies.
Varenicline for Smoking Cessation in Pancreatitis
Sponsor: Mayo Clinic
Summary
This study will look at how safe and how effective varenicline, a commonly used medication for smoking cessation, is in helping patients with pancreatitis stop smoking cigarettes. Individuals who agree to be part of the study will be treated with varenicline for 12 weeks, after which the investigators will see how many have stopped smoking.
Official title: Varenicline for Smoking Cessation in Pancreatitis: An Open-Label Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2026-11-13
Completion Date
2029-11-01
Last Updated
2026-10-19
Healthy Volunteers
No
Interventions
Varenicline (VAR)
Varenicline is the treatment being offered in this treatment. Treatment will entail oral varenicline 1 mg twice a day (BID) for a total of 12 weeks. Initial titration begins in the following manner: * Days 1-3: 0.5 mg once daily * Days 4-7: 0.5 mg twice daily * Day 8 through end of treatment (12 weeks): 1 mg twice daily
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States